The effect of Rosuvastatin on wound healing

The effect of Rosuvastatin on operative wounds

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120118008769N2

Enrollment

Registered

2019-11-02

Start date

2019-11-22

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Operative wound.

Interventions

Intervention 1: Intervention group: Patients receiving composition of Rosuvastatin 2% in Carboxymethyl Cellulose. Intervention 2: Control group: patients receiving Carboxymethyl Cellulose.

Eligibility

Sex/Gender

All

Age

11 Years to No maximum

Inclusion criteria

Inclusion criteria: Wounds due to operative incision

Exclusion criteria

Exclusion criteria: Age below 11 years old Malignant wound Traumatic wound Infectious and dirty wound Oral statin consumption Opioid addiction Comorbidity ( uncontrolled diabetes mellitus, immunosuppression , cirrhosis, renal failure)

Design outcomes

Primary

Measure	Time frame
"primary wound healing period" "complete wound healing (epithelialization) period". Timepoint: Measurements are taken daily from the start of the intervention. Method of measurement: Using the definitions of the two variables above in the surgical references , it is measured qualitatively by the physician.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactseied jalal eshagh hosseini

Ghoum University of Medical Sciences

j.hosseini@muq.ac.ir+98 25 3612 2827

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026